Clinical Trials | February 21, 2023
Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test
Experts’ conclave to pave holistic approach to cancer management
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
